Researchers discover molecule in immune system that could help treat dangerous skin cancer
Researchers from Brigham and Women's Hospital (BWH) have found, in a study in mice, that high expression of a cell-signaling molecule, known as interleukin-9, in immune cells inhibits melanoma growth. Brigham and Women's Hospital is part of the Dana-Farber/Harvard Cancer Center.
Among the research institutions NCI funds across the United States, it currently designates 66 as Cancer Centers. Largely based in research universities, these facilities are home to many of the NCI-supported scientists who conduct a wide range of intense, laboratory research into cancer’s origins and development. The Cancer Centers Program also focuses on trans-disciplinary research, including population science and clinical research. The centers’ research results are often at the forefront of studies in the cancer field.